Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NeoPharm Co. Ltd. (092730.KQ)
Daejeon, KR
Established on July 1, 2000, NeoPharm Co., Ltd. is a Daejeon, South Korea-based company that develops, produces, and markets a diverse range of cosmetic, medical, and health products. Its offerings notably include advanced skincare formulations, both emulsified and functional, designed to address issues such as sensitive and dry skin, as well as to provide treatment for atopic dermatitis, psoriasis, and the adverse effects associated with steroid use.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
35.96B
est: 25.40B (+41.6%)
|
42.37B
est: 42.40B (-0.1%)
|
53.63B
est: 52.96B (+1.3%)
|
66.27B
est: 66.37B (-0.1%)
|
83.24B
est: 84.96B (-2.0%)
|
81.63B
est: 81.33B (+0.4%)
|
87.93B
est: 89.45B (-1.7%)
|
85.03B
est: 98.00B (-13.2%)
|
97.10B
est: 96.60B (+0.5%)
|
119.01B
est: 120.00B (-0.8%)
|
132.18B
est: 132.40B (-0.2%)
|
154.00B
154.00B – 154.00B
+16.3% YoY
|
178.00B
178.00B – 178.00B
+15.6% YoY
|
| EBITDA |
5.25B
est: 7.52B (-30.1%)
|
10.27B
est: 12.55B (-18.2%)
|
14.83B
est: 15.67B (-5.4%)
|
20.62B
est: 19.64B (+5.0%)
|
24.76B
est: 25.15B (-1.5%)
|
24.44B
est: 24.07B (+1.6%)
|
25.32B
est: 26.47B (-4.3%)
|
24.90B
est: 29.00B (-14.2%)
|
31.01B
est: 28.59B (+8.5%)
|
33.35B
est: 34.12B (-2.3%)
|
31.88B
est: 37.64B (-15.3%)
|
43.78B
43.78B – 43.78B
+16.3% YoY
|
50.61B
50.61B – 50.61B
+15.6% YoY
|
| EBIT |
4.32B
est: 7.03B (-38.5%)
|
9.44B
est: 11.74B (-19.6%)
|
14.03B
est: 14.66B (-4.3%)
|
19.79B
est: 18.37B (+7.7%)
|
23.56B
est: 23.52B (+0.2%)
|
22.99B
est: 22.51B (+2.1%)
|
23.87B
est: 24.76B (-3.6%)
|
23.33B
est: 27.12B (-14.0%)
|
29.39B
est: 26.74B (+9.9%)
|
30.25B
est: 31.68B (-4.5%)
|
28.77B
est: 34.95B (-17.7%)
|
40.65B
40.65B – 40.65B
+16.3% YoY
|
46.99B
46.99B – 46.99B
+15.6% YoY
|
| Net Income |
3.41B
|
7.74B
est: 8.09B (-4.3%)
|
11.56B
est: 11.57B (-0.1%)
|
15.37B
est: 15.83B (-2.9%)
|
19.25B
est: 19.01B (+1.2%)
|
18.13B
est: 16.23B (+11.7%)
|
17.71B
est: 17.40B (+1.8%)
|
17.03B
est: 19.07B (-10.7%)
|
23.21B
est: 22.05B (+5.3%)
|
23.06B
est: 21.85B (+5.6%)
|
27.91B
est: 25.71B (+8.5%)
|
31.98B
31.98B – 31.98B
+24.4% YoY
|
36.39B
36.39B – 36.39B
+13.8% YoY
|
| SGA |
17.98B
est: 9.43B (+90.6%)
|
19.65B
est: 15.74B (+24.8%)
|
23.63B
est: 19.67B (+20.1%)
|
26.27B
est: 24.64B (+6.6%)
|
33.96B
est: 31.55B (+7.6%)
|
32.99B
est: 30.20B (+9.2%)
|
36.02B
est: 33.22B (+8.4%)
|
32.98B
est: 36.39B (-9.4%)
|
36.28B
est: 35.87B (+1.1%)
|
33.49B
est: 42.15B (-20.5%)
|
40.14B
est: 46.50B (-13.7%)
|
54.09B
54.09B – 54.09B
+16.3% YoY
|
62.52B
62.52B – 62.52B
+15.6% YoY
|
| EPS |
481.61
|
1,094.42
est: 517.50 (+111.5%)
|
1,633.93
est: 739.50 (+121.0%)
|
2,172.55
est: 1,012.17 (+114.6%)
|
2,569.66
est: 1,215.50 (+111.4%)
|
1,159.00
est: 1,037.88 (+11.7%)
|
1,132.50
est: 1,112.75 (+1.8%)
|
1,088.50
est: 1,219.50 (-10.7%)
|
1,484.00
est: 1,410.00 (+5.2%)
|
1,473.56
est: 1,398.50 (+5.4%)
|
1,778.81
est: 1,645.50 (+8.1%)
|
2,047.00
2,047.00 – 2,047.00
+24.4% YoY
|
2,329.00
2,329.00 – 2,329.00
+13.8% YoY
|
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 092730.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
